Your browser doesn't support javascript.
loading
Successful tapering of dupilumab in patients with atopic dermatitis with low disease activity: a large pragmatic daily practice study from the BioDay registry.
Spekhorst, Lotte S; Boesjes, Celeste M; Loman, Laura; Zuithoff, Nicolaas P A; Bakker, Daphne S; Kamphuis, Esmé; Kamsteeg, Marijke; Haeck, Inge M; Oosting, Albert J; van Lumig, Paula P M; van Lynden-van Nes, Anneke M T; Tupker, Ron A; Flinterman, Annebeth; Garritsen, Floor M; Touwslager, Wouter R H; de Bruin-Weller, Marjolein S; Schuttelaar, Marie-Louise A; de Graaf, Marlies.
Affiliation
  • Spekhorst LS; National Expertise Center for Atopic Dermatitis, Department of Dermatology and Allergology, University Medical Center Utrecht, Utrecht, the Netherlands.
  • Boesjes CM; National Expertise Center for Atopic Dermatitis, Department of Dermatology and Allergology, University Medical Center Utrecht, Utrecht, the Netherlands.
  • Loman L; Department of Dermatology, University Medical Center Groningen, Groningen, the Netherlands.
  • Zuithoff NPA; Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, the Netherlands.
  • Bakker DS; National Expertise Center for Atopic Dermatitis, Department of Dermatology and Allergology, University Medical Center Utrecht, Utrecht, the Netherlands.
  • Kamphuis E; Department of Dermatology, University Medical Center Groningen, Groningen, the Netherlands.
  • Kamsteeg M; Department of Dermatology, Radboud University Medical Center, Nijmegen, the Netherlands.
  • Haeck IM; Department of Dermatology, Reinier de Graaf Hospital, Delft, the Netherlands.
  • Oosting AJ; Department of Dermatology, Spaarne Gasthuis, Hoofddorp, the Netherlands.
  • van Lumig PPM; Department of Dermatology, University Medical Center Maastricht, Maastricht, the Netherlands.
  • van Lynden-van Nes AMT; Department of Dermatology, Meander Medical Center, Amersfoort, the Netherlands.
  • Tupker RA; Department of Dermatology, St Antonius Hospital, Nieuwegein, the Netherlands.
  • Flinterman A; Department of Dermatology, Diakonessenhuis, Utrecht, the Netherlands.
  • Garritsen FM; Department of Dermatology, Haga Hospital, Den Haag, the Netherlands.
  • Touwslager WRH; Department of Dermatology, Catharina Hospital, Eindhoven, the Netherlands.
  • de Bruin-Weller MS; National Expertise Center for Atopic Dermatitis, Department of Dermatology and Allergology, University Medical Center Utrecht, Utrecht, the Netherlands.
  • Schuttelaar MA; Department of Dermatology, University Medical Center Groningen, Groningen, the Netherlands.
  • de Graaf M; National Expertise Center for Atopic Dermatitis, Department of Dermatology and Allergology, University Medical Center Utrecht, Utrecht, the Netherlands.
Br J Dermatol ; 189(3): 327-335, 2023 08 24.
Article in En | MEDLINE | ID: mdl-37177895
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Dermatitis, Atopic Type of study: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Humans Language: En Year: 2023 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Dermatitis, Atopic Type of study: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Humans Language: En Year: 2023 Type: Article